Process Development

At Cambrex, we take a proactive and phase-appropriate approach to pharmaceutical process development and validation. Early drug development studies are traditionally designed to support fit-for-purpose manufacture of early clinical materials. As molecules progress, we help to create more cost-effective, robust and safe processes to manufacture the active pharmaceutical ingredient (API) for pilot and commercial production. Cambrex excels at turning early “med-chem” routes into commercially viable manufacturing routes during the drug development cycle.

We are structured to oversee custom small-molecule process development from early clinical phase to commercial production, and we offer a flexible manufacturing landscape, with small-, mid- and large-scale facilities designed to support customized solutions and seamless transfer of technologies.

Our development teams specialize in finding creative solutions to early-phase challenges while remaining focused on the rigors of validation. As a result, we can help you to avoid late-stage process changes, which could impact your speed to market. The result is more efficient preparation of your APIs and intermediates and greater confidence in your project’s success.


Discover a different CDMO

Looking for a partner that balances passion with painstaking attention to detail? Speak to one of our process development experts about how we can help you succeed.

Get in touch with an expert

Be the first to receive our latest news and updates